T. Rowe Price Associates’s Hims & Hers Health HIMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.1M | Sell |
563,877
-84,895
| -13% | -$4.23M | ﹤0.01% | 884 |
|
|
2025
Q1 | $19.2M | Buy |
648,772
+228,424
| +54% | +$6.75M | ﹤0.01% | 966 |
|
|
2024
Q4 | $10.2M | Buy |
420,348
+312,908
| +291% | +$7.57M | ﹤0.01% | 1143 |
|
|
2024
Q3 | $1.98M | Sell |
107,440
-87,997
| -45% | -$1.62M | ﹤0.01% | 1640 |
|
|
2024
Q2 | $3.95M | Buy |
195,437
+27,010
| +16% | +$545K | ﹤0.01% | 1293 |
|
|
2024
Q1 | $2.61M | Buy |
168,427
+118,848
| +240% | +$1.84M | ﹤0.01% | 1449 |
|
|
2023
Q4 | $442K | Buy |
49,579
+2,922
| +6% | +$26.1K | ﹤0.01% | 2228 |
|
|
2023
Q3 | $294K | Sell |
46,657
-21,875
| -32% | -$138K | ﹤0.01% | 2338 |
|
|
2023
Q2 | $645K | Sell |
68,532
-28,489
| -29% | -$268K | ﹤0.01% | 2013 |
|
|
2023
Q1 | $963K | Buy |
97,021
+35,748
| +58% | +$355K | ﹤0.01% | 1806 |
|
|
2022
Q4 | $393K | Sell |
61,273
-9,507
| -13% | -$61K | ﹤0.01% | 2251 |
|
|
2022
Q3 | $395K | Buy |
70,780
+20,099
| +40% | +$112K | ﹤0.01% | 2244 |
|
|
2022
Q2 | $230K | Buy |
50,681
+11,581
| +30% | +$52.6K | ﹤0.01% | 2535 |
|
|
2022
Q1 | $208K | Hold |
39,100
| – | – | ﹤0.01% | 2690 |
|
|
2021
Q4 | $256K | Buy |
+39,100
| New | +$256K | ﹤0.01% | 2660 |
|